Core Viewpoint - Lucid Group's stock price continues to decline despite significant capital investments and an award-winning vehicle lineup, indicating that only aggressive investors should consider buying the stock while it trades below $11 per share [1]. Group 1: Company Overview - Lucid is an auto manufacturer specializing in high-end electric vehicles (EVs), but the critical aspect is the need for substantial supporting infrastructure to build and sell cars [2]. - The company is still in start-up mode, focusing on building its manufacturing and sales platform to compete with established industry giants [3]. Group 2: Financial Health - Lucid has substantial capital investment requirements and has indicated it only has enough cash to fund operations through the first half of 2027, which may serve as a warning for most investors [3]. - The company is currently losing money and has only six quarters of cash remaining, raising concerns about its ability to attract new investors for necessary capital [4]. Group 3: Stock Performance - Lucid's stock price is currently just above $10 per share, but this figure is misleading due to a 1-for-10 reverse stock split enacted in August 2025, which was a preemptive measure to avoid delisting risks [6][7]. - Since the reverse stock split, the stock has dropped another 49%, reflecting Wall Street's skepticism about Lucid's future [10]. Group 4: Competitive Landscape - The EV market is highly competitive, with major automakers and successful pure-play EV makers vying for market share, making it challenging for Lucid to establish itself as a significant player [11]. - Despite producing 18,378 vehicles in Q4 2025, a 104% year-over-year increase, this volume is still minimal compared to larger competitors, highlighting the importance of scale in the industry [11]. Group 5: Investment Sentiment - The reverse stock split and ongoing losses suggest that most investors should avoid Lucid, viewing these developments as warning signs, with only the most aggressive investors advised to consider ownership [12].

Core Viewpoint - Urban One, Inc. has announced a reverse stock split of its common stock at a ratio of 10 for 1 to comply with Nasdaq's minimum bid price requirement for its Class D Common Stock [1][2]. Group 1: Reverse Stock Split Details - The reverse stock split will take effect at 11:59 p.m. on January 22, 2026, with trading on a split-adjusted basis starting on January 23, 2026 [3]. - Every 10 shares of Class A and Class D Common Stock will be converted into one share of the respective class [4]. - No fractional shares will be issued; instead, stockholders will receive cash equivalent to the closing sales price on the Effective Date for any fractional shares [5]. Group 2: Impact on Shareholders - The reverse stock split will be applied uniformly across all classes of common stock, ensuring that stockholders' percentage of ownership and voting power remains unchanged, aside from minor adjustments due to fractional shares [6]. - The reverse stock split will not affect the company's underlying business operations or total stockholders' equity [6]. Group 3: Company Overview - Urban One, Inc. is the largest diversified media company targeting Black Americans and urban consumers in the U.S., owning TV One and operating 74 broadcast stations across major African-American markets [7]. - The company also has a controlling interest in Reach Media, Inc., providing syndicated programming, and owns iOne Digital, a platform serving the African American community through various digital brands [7].

Core Insights - Figma, a collaborative design platform, saw its share price more than quadruple on its IPO day but subsequently lost most of those gains in the following months [1][2] Company Overview - Figma provides a web-based collaborative design architecture that allows design teams to work together in real-time on digital products such as websites and mobile apps [7][8] - The company has shown strong results in the quarters following its IPO [8] Stock Performance and Analysis - Figma's current share price is under $40, indicating it does not face issues related to high share prices that could necessitate a stock split [6] - The company is not a candidate for a reverse stock split, as it is not trading below the minimum levels set by major stock markets [6] - Despite the initial hype leading to a decline in value, Figma's stock is now considered reasonably priced, suggesting potential for recovery in the future [7]

Core Viewpoint - 60 Degree Pharmaceuticals, Inc. will implement a one-for-four (1:4) reverse stock split to comply with Nasdaq's minimum bid price requirement, effective January 20, 2026 [1][2] Group 1: Reverse Stock Split Details - The reverse stock split will reduce the number of outstanding shares from approximately 5,148,767 to about 1,287,192 [5] - All issued and outstanding shares, options, restricted stock awards, warrants, and other securities will be adjusted accordingly, with no fractional shares issued [4] - The par value of the Common Stock will remain unchanged at $0.0001 per share, and the authorized number of shares will not change [4] Group 2: Approval Process - Stockholders approved the reverse split proposal at a special meeting on October 8, 2025, allowing the board to file an amendment to effect the split [3] - The board officially approved the reverse split on December 17, 2025, and the amendment has been filed with the Secretary of State of Delaware [3] Group 3: Company Overview - 60 Degrees Pharmaceuticals, Inc. specializes in developing new medicines for vector-borne diseases and received FDA approval for its lead product, ARAKODA, in 2018 [6] - The company is headquartered in Washington, D.C., with a subsidiary in Australia and collaborates with prominent research organizations [6]

Core Viewpoint - Psyence Biomedical Ltd. has announced a 1-for-6.25 share consolidation, effective January 20, 2026, following prior approvals for share consolidations at different ratios [1][2][3]. Group 1: Share Consolidation Details - The share consolidation will combine every 6.25 issued and outstanding shares into one common share, resulting in a total of 1,022,177 common shares outstanding post-consolidation [3]. - The consolidation was approved by shareholders at a Special Meeting on April 16, 2025, allowing the Board of Directors to implement a consolidation ratio of up to 1-for-50 [1]. - The Company had previously authorized a 1-for-7.97 consolidation ratio, which was implemented on May 5, 2025 [1]. Group 2: Trading and Adjustments - Post-consolidation, the common shares will continue to trade under the symbol "PBM" on the Nasdaq Capital Market, with a new CUSIP number 74449F407 [2]. - The number of shares and the exercise price of outstanding warrants and other equity instruments will be adjusted proportionately according to their respective terms [3]. Group 3: Shareholder Impact - No fractional shares will be issued; any resulting fractions will be rounded to the nearest whole share [4]. - The consolidation affects all shareholders uniformly, with minor adjustments for fractional shares [4]. - Beneficial holders may experience delays in the reflection of the consolidation in their accounts, depending on their broker's procedures [4][5]. Group 4: Company Overview - Psyence Biomedical Ltd. is a biopharmaceutical company specializing in psychedelic-based therapeutics, focusing on nature-derived psilocybin and ibogaine-based medicines [6]. - The Company aims to address unmet mental health needs through evidence-based approaches in developing safe and effective treatments [6].

Core Viewpoint - Amcor PLC is a leading player in the global packaging industry, demonstrating strong financial performance and commitment to shareholder value through consistent dividend increases and strategic moves like a reverse stock split [1][2][5]. Financial Performance - Amcor's revenue has grown significantly from $4 billion in fiscal year 2017 to $15 billion in fiscal year 2025, reflecting a compound annual growth rate of 15.8% [3][5]. - The recent merger with Berry has positioned Amcor as the largest consumer packaging company globally, enhancing its economies of scale [3]. Stock Performance - Currently, Amcor's stock is trading at $8.65, with a slight decrease of 0.17% today, and has fluctuated between $8.61 and $8.67 [4]. - The stock has a 52-week high of $10.45 and a low of $7.67, indicating some volatility in the market [4]. - Amcor appears undervalued, trading at 10 times its projected free cash flow for fiscal year 2026, suggesting an attractive valuation for investors [4][5]. Corporate Actions - On January 15, 2026, Amcor will implement a reverse stock split, exchanging 1 share for every 5 shares, aimed at increasing the stock price by reducing the number of shares outstanding [2][5]. - The company has increased its dividend for seven consecutive years, appealing to income growth investors [2].

Core Insights - Noodles & Company reported a 6.6% increase in same-store sales for Q4 2025, with a notable growth of 7.3% at company-owned restaurants and 3.8% at franchises [1][2] Group 1: Financial Performance - The company ended the year with 340 company-owned and 83 franchised restaurants, planning to close an additional 30 to 35 locations in 2026 after closing 42 restaurants in the previous year [2] - CEO Joe Christina highlighted the positive sales growth as a continuation of a trend from Q3, attributing it to disciplined execution and enhancements in food quality [3][4] Group 2: Strategic Decisions - The closures are part of a "portfolio optimization" strategy aimed at focusing resources on the most promising locations to drive top-line growth [4] - The company is under pressure from activist investor Galloway Capital Partners to sell approximately 200 restaurants and has engaged Piper Sandler to explore options for maximizing shareholder value [4] Group 3: Shareholder Actions - Noodles & Company is facing potential delisting from Nasdaq due to share prices remaining below $1 for over six months, and a reverse stock split is proposed to increase share value [4] - Retention bonuses have been announced for executives in the event of a sale, with significant bonuses tied to their base salaries [4]

Core Viewpoint - VS Media Holdings Limited (VSME) is undergoing a reverse stock split to comply with Nasdaq listing requirements, with the split date delayed to January 12, 2026 due to regulatory approval issues [2][5]. Group 1: Company Overview - VSME operates in the digital content creation industry, collaborating with over 1,500 creators and more than 1,000 brands in the Asia Pacific region [1]. - The company focuses on content-driven social commerce and marketing services [1]. Group 2: Stock Performance - VSME's stock has shown volatility, with a recent opening price of $0.09 and a 52-week range of $0.07 to $3.21 [3]. - The fifty-day moving average price is $0.26, while the 200-day moving average price is $1.16 [3]. - The latest quarterly earnings report indicated a loss of $0.10 per share and revenue of $1.63 million [3]. Group 3: Analyst Opinions - Analysts have mixed views on VSME's future, with Weiss Ratings maintaining a "sell (e+)" rating and Wall Street Zen upgrading it to a "hold" rating [4]. - The current stock price is $0.08, reflecting a decrease of 2.19% with a change of -$0.0018 [4]. - VSME's market capitalization is approximately $3.96 million, with a trading volume of 1,988,184 shares [4].

Core Viewpoint - Noodles & Company is facing imminent delisting from the Nasdaq Stock Market due to its stock price falling below the required minimum of $1 per share, with a current price of 63 cents as of December 22, 2025 [1] Group 1: Delisting and Compliance - The company received a delisting warning on June 24, 2025, and was given 180 days to comply with the minimum share price requirement [2] - Noodles & Company plans to request a hearing to stay the delisting process, which will allow it to continue trading while the hearing is pending [2] - A special stockholder meeting is scheduled for February 4, where the company will propose a reverse stock split to increase its share price [2] Group 2: Financial Performance and Strategy - The company has been attempting a turnaround for over a year, launching a revamped menu and operational improvements [4] - For the quarter ending September 30, the company reported a 4% increase in same-store sales, with October showing an 8% increase, despite a 0.5% decrease in total revenue and a net loss of $9.2 million [4] - Noodles & Company has engaged Piper Sandler to explore options for maximizing shareholder value, including a potential sale of the company [4] Group 3: Investor Actions - Activist investor Galloway Capital Partners has urged Noodles & Company to sell approximately 200 of its 349 company-owned restaurants [4]

Core Viewpoint - Co-Diagnostics (CODX) has announced a reverse stock split at a ratio of 1-for-30 shares to comply with Nasdaq's minimum bid price requirement [1] Group 1: Reverse Stock Split Details - The reverse stock split will take effect at 12:01 a.m. ET on January 2, 2026 [1] - Co-Dx's common stock will continue to trade on The Nasdaq Capital Market under the symbol "CODX" and will begin trading on a split-adjusted basis on the same date [1] - The new CUSIP number for Co-Dx's common stock after the reverse stock split will be 189763 204 [1] Group 2: Compliance and Listing - The purpose of the reverse stock split is to enable Co-Diagnostics to regain compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market [1]